KATE BREINER: Open Payments
NPI 1477205185 · MONROE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,696 in 120 payments from 38 companies in 2025. Trend: 2023 $3,044 · 2024 $2,414 · 2025 $2,696
Food & beverage: $2,696
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $340 |
| ABBVIE INC. | 14 | $275 |
| Merck Sharp & Dohme LLC | 11 | $274 |
| GlaxoSmithKline, LLC. | 6 | $152 |
| Gilead Sciences, Inc. | 6 | $140 |
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| JAZZ PHARMACEUTICALS INC. | 4 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $102 |
| SOBI, INC | 5 | $96 |
| Genentech USA, Inc. | 3 | $65 |
Products named: KEYTRUDA, KISQALI, Trodelvy, EPKINLY, Nubeqa, ZEPZELCA, Venclexta, SCEMBLIX.
Industry payments across GA — which companies pay providers there.
